Want to join the conversation?
$MYL said the US Patent and Trademark Office has ruled in its favor and found all claims of 2 related patents of Copaxone 40 mg/mL owned by Yeda Research and licensed to Teva Pharmaceuticals to be unpatentable. A decision by the Patent Trial and Appeal Board on $MYL's third petition is expected on or before Sept. 1.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.